Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure

NCT03549832 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HCV Coinfection

Interventions

DRUG: Sofosbuvir
DRUG: Simeprevir
DRUG: Daclatasvir
DRUG: Ribavirin
DRUG: Ombitasvir/paritaprevir/ritonavir

Sponsor

Assiut University

Collaborators

[object Object]
[object Object]